Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Patients with Cystic Fibrosis

Clicks: 9
ID: 328174
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #244 of 247 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 247 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
PURPOSE: Pharmacist inclusion in the cystic fibrosis (CF) multidisciplinary care team is essential to optimize patient management and outcomes. We evaluated the impact of an integrated health system specialty pharmacy (HSSP) model paired with a pharmacist-led collaborative drug therapy management (CDTM) program on outcomes for people with CF (pwCF). SUMMARY: In a single-center, retrospective, observational cohort study of 191 pwCF (52% male, mean age of 23) from an academic medical center who were filling prescriptions at the affiliated HSSP and enrolled in the CDTM program from September 2023 to September 2024, 67% were initiated in fewer than two days and 78% had a proportion of days covered > 80%. The average medication out-of-pocket cost for the cohort was $5.14 per prescription, with 91% having no copay. Over 12 months, there were three unplanned emergency department visits, five hospitalizations, and seven CF pulmonary exacerbations reported. CONCLUSIONS: The integration of a CDTM program with a HSSP demonstrated positive outcomes for pwCF, highlighting the value of an integrated pharmacy model and role of pharmacists in the CF care team.
Reference Key
openalex_W7212075994 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vi Nguyen, Martha Stutsky, Sarah Kubiak, R. Perkins, Shreevidya Periyasamy, Y Caleb Chun
Are you one of these authors? Claim your profile
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag275
URL
https://doi.org/10.1093/ajhp/zxag275
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.